echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Pfizer's 20-valent pneumococcal polysaccharide conjugate vaccine declares for clinical application in China

    Pfizer's 20-valent pneumococcal polysaccharide conjugate vaccine declares for clinical application in China

    • Last Update: 2022-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Cube Info

    Author: info

    On April 1, the CDE official website showed that Pfizer's 20-valent pneumococcal polysaccharide conjugate vaccine (PREVNAR 20, PCV20) has been accepted by the State Food and Drug Administration for clinical applications in China


    The product was approved by the U.


    PREVNAR 20 is an upgraded version of Pfizer's ace product PCV13 (Prevnar 13).


    According to the financial report, PCV13 and PCV20 will bring Pfizer $5.


    It is reported that domestic companies Wantai Bio/Jiangsu Kunli are also developing a 20-valent pneumococcal polysaccharide conjugate vaccine


    On January 29, 2021, Wantai Bio and Jiangsu Kunli signed the "Pneumonia 20-valent Pneumonia Candidate Vaccine Licensing Agreement", and the production, manufacture and sale of the pneumolysin-carrier 20-valent pneumococcal polysaccharide protein conjugate vaccine in mainland China Transfer of rights (exclusive license) to Wantai Bio


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.